3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
A clinical breakdown of Ozempic (semaglutide) adverse events by frequency, severity grade, and patient phenotype, drawing on SUSTAIN trial data, FDA FAERS reports, and post-market literature.
A guide to the rare but serious adverse events associated with Ozempic (semaglutide 0.5 to 2.0 mg), including pancreatitis, thyroid tumors, gastroparesis, vision changes, and suicidality signals, with trial data, FDA labeling, and FAERS reporting.
What happens when you stop Ozempic? This clinical guide covers weight regain, rebound hunger, GI symptoms, cardiovascular implications, and evidence-based strategies to minimize discontinuation effects.